Southwest Securities released a research report on April 22 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) steady growth in growth hormone; 2) continued dosage of the shingles vaccine; 3)

Zhitong Finance · Apr 23 16:25

Southwest Securities released a research report on April 22 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) steady growth in growth hormone; 2) continued dosage of the shingles vaccine; 3) the proprietary Chinese medicine business has remained stable, and the real estate sector is growing rapidly. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

西南证券4月22日发布研报称，给予长春高新（000661.SZ）买入评级。评级理由主要包括：1）生长激素稳健增长；2）带状疱疹疫苗持续放量；3）中成药业务基本保持平稳，地产板块增速较快。（每日经济新闻）

Southwest Securities released a research report on April 22 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) steady growth in growth hormone; 2) continued dosage of the shingles vaccine; 3)

Risk Disclaimer

Statement